Hab Pharma

Hab Pharma, established in 1980, is a leading Indian pharmaceutical manufacturer known for WHO-GMP compliant facilities, research-driven innovation, and high-quality formulations. With advanced manufacturing units in Mumbai and Dehradun, Hab Pharma serves domestic and global markets with a diverse portfolio of tablets, capsules, ointments, sprays, and specialty medicines. Backed by strong R&D capabilities and strict quality standards, Hab Pharma continues to deliver reliable, safe, and effective healthcare solutions worldwide.

[hab-pharma]

Hab Pharma Recognized at Bombay Chamber DEI Awards 2025

Proud moment for Hab Pharma! The company was honored with the Special Award for MSMEs at the Bombay Chamber DEI Awards 2025, recognizing its commitment to fostering diversity, equity, and inclusion (DEI) in the workplace. The event, hosted in Mumbai, brought together industry leaders to highlight initiatives that promote inclusive growth and equitable corporate cultures across India.

Such recognition reflects Hab Pharma’s dedication to building a responsible, inclusive, and forward-looking organization that values people, innovation, and sustainable growth.

[hab-pharma]

Pharma’s Digital Shift Is Redefining Healthcare Marketing

The pharmaceutical industry is rapidly embracing digital transformation. According to a recent industry report, pharma brands have increased their digital media allocation from 54% in 2024 to 67% in 2025, highlighting a major shift toward digital-first engagement with doctors, pharmacists, and patients. This transformation reflects how healthcare information and decision-making are increasingly happening online.

As the industry evolves, digital platforms are becoming essential for education, awareness, and responsible communication in regulated sectors like pharmaceuticals.

Pharma’s digital acceleration signals structural reset in regulated advertising - Exchange4media

According to the dentsu-e4m Digital Advertising Report, pharma increased its digital allocation from 54% in 2024 to 67% in 2025

[hab-pharma]

Hab Pharma’s Community Wellness Initiatives

Hab Pharma actively supports diabetes screening and health outreach in underserved areas through partnerships and CSR programs — strengthening community well-being.

Hab Pharma

[hab-pharma]

Making Healthcare Accessible Through CSR

Through initiatives with leading partners like JVAC, Hab Pharma contributes to broader social goals — from autism care to community health empowerment. Let’s build an inclusive future together.

HAB Pharmaceuticals and Research partners with Jai Vakeel Autism Centre

To provide education, skills and healthcare to children diagnosed with Autism Spectrum Disorder HAB Pharmaceuticals and Research (HAB) has p

[hab-pharma]

Expanding CSR Reach Beyond Medicines

Hab Pharma’s CSR efforts extend to empowering autistic children, reinforcing our belief that healthcare goes beyond treatments to include education, integration, and real-world support.

World Autism Awareness Day: CSR Initiatives for Individuals with Autism - The CSR Journal

CSR Initiatives for Individuals with Autism CSR Initiatives for Individuals with Autism CSR Initiatives for Individuals with Autism

[hab-pharma]

Enhancing Support for Neurodiverse Communities

We’re thrilled to share Hab Pharma’s collaboration with JVAC, helping strengthen programs focused on language, social interaction, and therapy support for autistic children.

HAB Pharma and JVAC Partner to Empower Autistic Children in India - The Times of India

Business News: Mumbai, Maharashtra, India (NewsVoir) HAB Pharmaceuticals and Research Ltd.

[hab-pharma]

Hab Pharma Partners With Jai Vakeel Autism Centre

Hab Pharma joined hands with Jai Vakeel Autism Centre to support education, skills development, and healthcare for children diagnosed with Autism Spectrum Disorder — a strong commitment toward inclusive community support.

HAB Pharma and JVAC Partner to Empower Autistic Children in India

[hab-pharma]

Navigating the Future of Digital Pharma

As pharma advertising undergoes structural change, Hab Pharma remains focused on compliance, transparency, and responsible digital engagement.

Pharma’s digital acceleration signals structural reset in regulated advertising - Exchange4media

According to the dentsu-e4m Digital Advertising Report, pharma increased its digital allocation from 54% in 2024 to 67% in 2025

[hab-pharma]

Scaling Infrastructure, Strengthening Innovation

The expansion of Hab Pharma’s infrastructure demonstrates our long-term strategy of combining innovation, research, and manufacturing excellence.

HAB Pharma Announces Major Expansion with Two New Plants

HAB Pharma Announces Major Expansion with Two New Plants

[hab-pharma]

Driving Inclusive Social Initiatives

Hab Pharma supports initiatives that promote awareness and inclusion, reflecting our broader vision of healthcare that extends beyond treatment.

World Autism Awareness Day: CSR Initiatives for Individuals with Autism - The CSR Journal

CSR Initiatives for Individuals with Autism CSR Initiatives for Individuals with Autism CSR Initiatives for Individuals with Autism

[hab-pharma]

Expanding Production for a Healthier Tomorrow

With new manufacturing facilities underway, Hab Pharma reinforces its commitment to quality pharmaceutical production and expanding healthcare access globally.

HAB Pharma Announces Major Expansion with Two New Plants

HAB Pharma Announces Major Expansion with Two New Plants

[hab-pharma]

Community Healthcare in Action

Hab Pharma’s participation in healthcare-driven community initiatives highlights our ongoing dedication to strengthening public health and supporting life-saving programs.

https://www.aninews.in/news/business/tarun-mitra-mandal-unites-community-volunteers-in-a-large-scale-blood-donation-drive-organised-by-hab-pharma20260127190241

[hab-pharma]

Embracing Digital Transformation in Pharma

The pharmaceutical industry is evolving through digital acceleration. Hab Pharma continues to align with regulated digital engagement and responsible communication practices.

Pharma’s digital acceleration signals structural reset in regulated advertising - Exchange4media

According to the dentsu-e4m Digital Advertising Report, pharma increased its digital allocation from 54% in 2024 to 67% in 2025

[hab-pharma]

Strengthening Community Impact Through CSR

Beyond medicines, Hab Pharma remains committed to meaningful corporate social responsibility initiatives that drive inclusion, awareness, and long-term community impact.

World Autism Awareness Day: CSR Initiatives for Individuals with Autism - The CSR Journal

CSR Initiatives for Individuals with Autism CSR Initiatives for Individuals with Autism CSR Initiatives for Individuals with Autism

[hab-pharma]

Hab Pharma Announces Major Manufacturing Expansion

Hab Pharma has announced the expansion of its manufacturing capabilities with two new plants, marking a significant milestone in innovation, production strength, and global pharmaceutical growth.

HAB Pharma Announces Major Expansion with Two New Plants

HAB Pharma Announces Major Expansion with Two New Plants

[hab-pharma]

Blood Donation Drive Initiative

Hab Pharma proudly supported a large-scale blood donation drive, bringing together community volunteers to strengthen healthcare support systems and save lives. A meaningful step towards social responsibility and community well-being.

https://www.aninews.in/news/business/tarun-mitra-mandal-unites-community-volunteers-in-a-large-scale-blood-donation-drive-organised-by-hab-pharma20260127190241